Multi-excitation fluorescence spectroscopy for analysis of non-alcoholic fatty liver disease

Lasers in Surgery and Medicine

Volumn 43, Issue 5, 2011, Pages 392-400

  Sauvage, Vincent R ^a   Levene, Adam P ^a   Nguyen, Hoa T ^a,b   Wood, Tobias C ^a   Kudo, Hiromi ^a   Concas, Danilo ^c   Thomas, Howard C ^a   Thursz, Mark R ^a   Goldin, Robert D ^a   Anstee, Quentin M ^c,d   Elson, Daniel S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Institut d'Alembert   (France)

^c MRC MAMMALIAN GENETICS UNIT   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

autofluorescence; endogenous fluorophores; laser diode; optical fibre probe; steatohepatitis; steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FLUORESCENCE SPECTROSCOPY; HISTOPATHOLOGY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ANIMALS; FATTY LIVER; LASERS, SEMICONDUCTOR; LIVER; LOGISTIC MODELS; MALE; MICE; SPECTROMETRY, FLUORESCENCE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 79959296581     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.21064     Document Type: Article

References (35)

1. Anstee QM, Goldin RD,. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 2006; 87 (1): 1-16.
2. Saadeh S, Younossi ZM,. The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis. Cleve Clin J Med 2000; 67 (2): 96-97.
3. El-Zayadi AR,. Hepatic steatosis: A benign disease or a silent killer. World J Gastroenterol 2008; 14 (26): 4120-4126.
4. Schreuder T, Verwer BJ, van Nieuwkerk CMJ, Mulder CJJ,. Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol 2008; 14 (16): 2474-2486. (Pubitemid 352037734)
5. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH,. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004; 40 (6): 1387-1395. (Pubitemid 39657013)
6. Tock L, Dâmaso AR, de Piano A, Carnier J, Sanches PL, Lederman HM, Ernandes RM, de Mello MT, Tufik S,. Long-term effects of metformin and lifestyle modification on nonalcoholic fatty liver disease obese adolescents. J Obes 2010; 2010.
7. WHO. Obesity and overweight. 2006; Available from:.
8. WHO. Diabetes-Key facts. 2010; Available from:.
9. Hashimoto K, Miller C,. The use of marginal grafts in liver transplantation. J Hepatobiliary Pancreat Surg 2008; 15 (2): 92-101. (Pubitemid 351516966)
10. Kim SH, Lee JM, Han JK, Lee JY, Lee KH, Han CJ, Jo JY, Yi NJ, Suh KS, Shin KS, Jo SY, Choi BI,. Hepatic macrosteatosis: Predicting appropriateness of liver donation by using MR imaging-Correlation with histopathologic findings. Radiology 2006; 240 (1): 116-129. (Pubitemid 43902601)
11. Nocito A, El-Badry AM, Clavien PA,. When is steatosis too much for transplantation? J Hepatol 2006; 45 (4): 494-499. (Pubitemid 44307398)
12. Bravo AA, Sheth SG, Chopra S,. Current concepts: Liver biopsy. N Engl J Med 2001; 344 (7): 495-500.
13. Graif M, Yanuka M, Baraz M, Blank A, Moshkovitz M, Kessler A, Gilat T, Weiss J, Walach E, Amazeen P, Irving CS,. Quantitative estimation of attenuation in ultrasound video images-Correlation with histology in diffuse liver disease. Invest Radiol 2000; 35 (5): 319-324. (Pubitemid 30395315)
14. Cheruku SM, Fishbein MH,. Hepatic MRI for fat quantitation: Its relationship to fat morphology, diagnosis and ultrasound. Gastroenterology 2004; 126 (4): A758-A758.
15. Foucher J, Castera L, Bernard PH, Adhoute X, Laharie D, Bertet J, Couzigou P, de Ledinghen V,. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006; 18 (4): 411-412.
16. Clark JM, Diehl AM,. Nonalcoholic fatty liver disease-An underrecognized cause of cryptogenic cirrhosis. JAMA 2003; 289 (22): 3000-3004. (Pubitemid 37430103)
17. Ramanujam N,. Fluorescence spectroscopy of neoplastic and non-neoplastic tissues. Neoplasia 2000; 2 (1-2): 89-117. (Pubitemid 30123183)
18. Croce AC, Ferrigno A, Vairetti M, Bertone R, Freitas I, Bottiroli G,. Autofluorescence properties of isolated rat hepatocytes under different metabolic conditions. Photochem Photobiol Sci 2004; 3 (10): 920-926.
19. Croce AC, De Simone U, Vairetti M, Ferrigno A, Bottiroli G,. Autofluorescence properties of rat liver under hypermetabolic conditions. Photochem Photobiol Sci 2007; 6: 1202-1209. (Pubitemid 350045986)
20. Croce AC, De Simone U, Vairetti M, Ferrigno A, Boncompagni E, Freitas I, Bottiroli G,. Liver autofluorescence properties in animal model under altered nutritional conditions. Photochem Photobiol Sci 2008; 7 (9): 1046-1053.
21. Croce AC, De Simone U, Freitas I, Boncompagni E, Neri D, Cillo U, Bottiroli G,. Human liver autofluorescence: An intrinsic tissue parameter discriminating normal and diseased conditions. Lasers Surg Med 2010; 42 (5): 371-378.
22. Yates CA, Evans GS, Powers HJ,. Riboflavin deficiency: Early effects on post-weaning development of the duodenum in rats. Br J Nutr 2001; 86 (5): 593-599. (Pubitemid 33138263)
23. Capdevila J, Chacos N, Werringloer J, Prough RA, Estabrook RW,. Liver microsomal cytochrome-P-450 and the oxidative-metabolism of arachidonic-acid. Proc Natl Acad Sci USA 1981; 78 (9): 5362-5366. (Pubitemid 12248586)
24. Bloomer JR,. Liver metabolism of porphyrins and haem. J Gastroenterol Hepatol 1998; 13 (3): 324-329. (Pubitemid 28183968)
25. Porta EA,. Ceroid and lipofuscin in the liver-History and its state-of-the-art. Liver Aging-1990 1991; 940: 89-105.
26. Wagnieres GA, Star WM, Wilson BC,. In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem Photobiol 1998; 68 (5): 603-632. (Pubitemid 128472287)
27. Krishnapuram B, Carin L, Figueiredo MAT, Hartemink AJ,. Sparse multinomial logistic regression: Fast algorithms and generalization bounds. IEEE Trans Pattern Anal Machine Intell 2005; 27 (6): 957-968. (Pubitemid 40889845)
28. Bosko J, Edwards M, Artemink A,. SMLR: Sparse Multinomial Logistic Regression. Available from:.
29. Majumder SK, Gebhart S, Johnson MD, Thompson R, Lin WC, Mahadevan-Jansen A,. A probability-based spectroscopic diagnostic algorithm for simultaneous discrimination of brain tumor and tumor margins from normal brain tissue. Appl Spectrosc 2007; 61 (5): 548-557. (Pubitemid 46770369)
30. Keller MD, Majumder SK, Kelley MC, Meszoely IM, Boulos FI, Olivares GM, Mahadevan-Jansen A,. Autofluorescence and diffuse reflectance spectroscopy and spectral imaging for breast surgical margin analysis. Lasers Surg Med 2010; 42 (1): 15-23.
31. Tibshirani R,. Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B 1996; 58 (1): 267-288.
32. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Clin NS,. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41 (6): 1313-1321. (Pubitemid 40770284)
33. Sankarankutty AK, Silva OCE, Ferreira J, Souza MEJ, Gomes MC, Kurachi C, Bagnato VS,. Use of laser auto-fluorescence for evaluating liver grafts. Laser Phys Lett 2006; 3 (11): 539-545.
34. De Oliveira GR, Sankarankutty AK, Castro e Silva O, Ferreira J, Kurachi C, Zucoloto S, Vannucchi H, Jordao AA, Marchini JS, Bagnato VS,. Fluorescence spectroscopy to diagnose hepatic steatosis in a rat model of fatty liver. Liver Int 2009; 29 (3): 331-336.
35. Sun CK, Zhang XY, Wheatley AM,. Increased NAD(P)H fluorescence with decreased blood flow in the steatotic liver of the obese Zucker rat. Microvasc Res 2003; 66 (1): 15-21. (Pubitemid 36765440)